USBiological
EL
IgG4,k
Reset all filters

Min CHF:
Max CHF:
  1-30 of 112
Supplier Product name Cat.no. Pack size Price
Anti- Amlitelimab 591663-100uG 882,00
Anti- Andecaliximab (MMP9) 591666-100uG 882,00
Anti- Atinumab (RTN4, NOGO) 591679-100uG 882,00
Anti- Axatilimab (CSF1R, CD115) 591684-100uG 882,00
Anti- Balstilimab (PDCD1, PD1, CD279) 591686-100uG 882,00
Anti- Bertilimumab (CCL11) 591707-100uG 882,00
Anti- Bleselumab (CD40, TNFRSF5) 591716-100uG 882,00
Anti- Blosozumab (SOST(sclerostin)) 591718-100uG 882,00
Anti- Cabiralizumab (CSF1R, CD115) 591730-100uG 882,00
Anti- Camrelizumab (PDCD1, PD-1, CD279) 591734-100uG 882,00
Anti- CDP571 (TNFSF2, TNF alpha, TNFA) 591743-100uG 882,00
Anti- Cemiplimab (PDCD1, PD1, CD279) 591744-100uG 882,00
Anti- Cetrelimab (PDCD1, PD1, CD279) 591747-100uG 882,00
Anti- Cobolimab (HAVCR2, TIM3, CD366) 591760-100uG 882,00
Anti- Concizumab (TFPI) 591765-100uG 882,00
Anti- Crenezumab (APP Abeta42 and Abeta40) 591769-100uG 882,00
Anti- Crotedumab (GCGR) 591771-100uG 882,00
Anti- Dostarlimab (PDCD1, PD1, CD279) 591801-100uG 882,00
Anti- Dupilumab (IL4R, CD124) 591804-100uG 882,00
Anti- Emibetuzumab (MET, RCCP2) 591825-100uG 882,00
Anti- Emicizumab (F10, F9 Activated Form) 591826-100uG 882,00
Anti- Encelimab (LAG3, CD223) 591829-100uG 882,00
Anti- Evinacumab (ANGPTL3) 591851-100uG 882,00
Anti- Ezabenlimab 591854-100uG 882,00
Anti- Fasinumab (NGF, NGFB) 591858-100uG 882,00
Anti- Feladilimab 591859-100uG 882,00
Anti- Fianlimab (LAG3, CD223) 591862-100uG 882,00
Anti- Finotonlimab 591865-100uG 882,00
Anti- Fletikumab (IL20) 591868-100uG 882,00
Anti- Fresolimumab (TGFB, TGF beta) 591874-100uG 882,00
  1-30 of 112

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
Monday to Friday
08:00 – 12:00
13:00 – 17:00

Technical Support
tech@lucerna-chem.ch
Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

© Copyright 2021 Lucerna-Chem AG, Switzerland

Order Conditions | Privacy Policy | Terms & Conditions | Impressum